Healthcare Realty Trust Inc HR.N, HR is expected to show a fall in quarterly revenue when it reports results on February 19 for the period ending December 31 2024
The Nashville Tennessee-based company is expected to report a 7.9% decrease in revenue to $304.34 million from $330.44 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data. (Revenue consensus is on Total Revenue Basis)
LSEG's mean analyst estimate for Healthcare Realty Trust Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Healthcare Realty Trust Inc is $18.00, above its last closing price of $16.49.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.38 | 0.38 | 0.39 | Beat | 1.5 |
Jun. 30 2024 | 0.38 | 0.38 | 0.38 | Met | -0.9 |
Mar. 31 2024 | 0.38 | 0.38 | 0.39 | Beat | 1.9 |
Dec. 31 2023 | 0.39 | 0.40 | 0.39 | Missed | -1.6 |
Sep. 30 2023 | 0.39 | 0.39 | 0.39 | Met | -0.2 |
Jun. 30 2023 | 0.40 | 0.40 | 0.39 | Missed | -2.3 |
Mar. 31 2023 | 0.41 | 0.41 | 0.40 | Missed | -2.7 |
Dec. 31 2022 | 0.40 | 0.40 | 0.42 | Beat | 5.1 |
This summary was machine generated February 17 at 13:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。
沒有相關數據
如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”